Chris Griffith Speaks at 3rd Annual China Pharma IP Summit

Chris Griffith and Jeff Ward were invited to attend the 3rd China Pharma IP Summit in Beijing held on October 24-26, 2018.

This event focused on a variety of IP topics pertinent to pharma stakeholders located in Asia, including pharma-related IP policies in China, as well as pharma patent examination, management and litigation in the U.S. and Europe. Chris presented on “Navigating the IP/FDA Exclusivity Waters – Recent Developments Affecting the Journey to 505(b)(1), 505(b)(2), ANDA and Biologics Approval in the US.”